Literature DB >> 21415417

Mitochondrial biogenesis fails in secondary biliary cirrhosis in rats leading to mitochondrial DNA depletion and deletions.

Alessandro Arduini1, Gaetano Serviddio, Javier Escobar, Ana M Tormos, Francesco Bellanti, José Viña, María Monsalve, Juan Sastre.   

Abstract

Chronic cholestasis is characterized by mitochondrial dysfunction, associated with loss of mitochondrial membrane potential, decreased activities of respiratory chain complexes, and ATP production. Our aim was to determine the molecular mechanisms that link long-term cholestasis to mitochondrial dysfunction. We studied a model of chronic cholestasis induced by bile duct ligation in rats. Key sensors and regulators of the energetic state and mitochondrial biogenesis, mitochondrial DNA (mtDNA)-to-nuclear DNA (nDNA) ratio (mtDNA/nDNA) relative copy number, mtDNA deletions, and indexes of apoptosis (BAX, BCL-2, and cleaved caspase 3) and cell proliferation (PCNA) were evaluated. Our results show that long-term cholestasis is associated with absence of activation of key sensors of the energetic state, evidenced by decreased SIRT1 and pyruvate dehydrogenase kinase levels and lack of AMPK activation. Key mitochondrial biogenesis regulators (PGC-1α and GABP-α) decreased and NRF-1 was not transcriptionally active. Mitochondrial transcription factor A (TFAM) protein levels increased transiently in liver mitochondria at 2 wk after bile duct ligation, but they dramatically decreased at 4 wk. Reduced TFAM levels at this stage were mirrored by a marked decrease (65%) in mtDNA/nDNA relative copy number. The blockade of mitochondrial biogenesis should not be ascribed to activation of apoptosis or inhibition of cell proliferation. Impaired mitochondrial turnover and loss of the DNA stabilizing effect of TFAM are likely the causative event involved in the genetic instability evidenced by accumulation of mtDNA deletions. In conclusion, the lack of stimulation of mitochondrial biogenesis leads to mtDNA severe depletion and deletions in long-term cholestasis. Hence, long-term cholestasis should be considered a secondary mitochondrial hepatopathy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21415417     DOI: 10.1152/ajpgi.00253.2010

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  15 in total

1.  The Effect of NeuroAid (MLC901) on Cholestasis-Induced Spatial Memory Impairment with Respect to the Expression of BAX, BCL-2, BAD, PGC-1α and TFAM Genes in the Hippocampus of Male Wistar Rats.

Authors:  Pejman Molaei; Salar Vaseghi; Maliheh Entezari; Mehrdad Hashemi; Mohammad Nasehi
Journal:  Neurochem Res       Date:  2021-05-24       Impact factor: 3.996

2.  Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid-fed mouse model of cholestasis.

Authors:  Supriya R Kulkarni; Carol J Soroka; Lee R Hagey; James L Boyer
Journal:  Hepatology       Date:  2016-10-28       Impact factor: 17.425

3.  Effect of cholestasis and NeuroAid treatment on the expression of Bax, Bcl-2, Pgc-1α and Tfam genes involved in apoptosis and mitochondrial biogenesis in the striatum of male rats.

Authors:  Mohammad Nasehi; Sepehr Torabinejad; Mehrdad Hashemi; Salar Vaseghi; Mohammad-Reza Zarrindast
Journal:  Metab Brain Dis       Date:  2019-11-26       Impact factor: 3.584

4.  Resveratrol effectively attenuates α-naphthyl-isothiocyanate-induced acute cholestasis and liver injury through choleretic and anti-inflammatory mechanisms.

Authors:  Tao Wang; Zhi-xing Zhou; Li-xin Sun; Xia Li; Zhi-meng Xu; Mi Chen; Guo-lin Zhao; Zhen-zhou Jiang; Lu-yong Zhang
Journal:  Acta Pharmacol Sin       Date:  2014-11-24       Impact factor: 6.150

5.  The novel growth factor, progranulin, stimulates mouse cholangiocyte proliferation via sirtuin-1-mediated inactivation of FOXO1.

Authors:  Gabriel Frampton; Yoshiyuki Ueno; Matthew Quinn; Matthew McMillin; Hae Yong Pae; Cheryl Galindo; Dinorah Leyva-Illades; Sharon DeMorrow
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-10-18       Impact factor: 4.052

6.  Genomic and non-genomic regulation of PGC1 isoforms by estrogen to increase cerebral vascular mitochondrial biogenesis and reactive oxygen species protection.

Authors:  Martin F Kemper; Chris Stirone; Diana N Krause; Sue P Duckles; Vincent Procaccio
Journal:  Eur J Pharmacol       Date:  2013-11-22       Impact factor: 4.432

7.  The effect of Crocin on TFAM and PGC-1α expression and Catalase and Superoxide dismutase activities following cholestasis-induced neuroinflammation in the striatum of male Wistar rats.

Authors:  Mohammad-Reza Eteghadi; Mohammad Nasehi; Salar Vaseghi; Saeed Hesami-Tackallou
Journal:  Metab Brain Dis       Date:  2021-05-21       Impact factor: 3.584

8.  Mitofusin 2 protects hepatocyte mitochondrial function from damage induced by GCDCA.

Authors:  Yongbiao Chen; Lizhi Lv; Zhelong Jiang; Hejun Yang; Song Li; Yi Jiang
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

9.  Caveolin-1 provides palliation for adverse hepatic reactions in hypercholesterolemic rabbits.

Authors:  Ya-Hui Chen; Wei-Wen Lin; Chin-San Liu; Li-Sung Hsu; Yueh-Min Lin; Shih-Li Su
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

10.  Rapamycin Attenuates Splenomegaly in both Intrahepatic and Prehepatic Portal Hypertensive Rats by Blocking mTOR Signaling Pathway.

Authors:  Yunyang Chen; Weijie Wang; Huakai Wang; Yongjian Li; Minmin Shi; Hongwei Li; Jiqi Yan
Journal:  PLoS One       Date:  2016-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.